Back to Search Start Over

Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers

Authors :
John Roberts
Margareta Linden
Camilla Cervin
Fredrik Tiberg
Source :
Endocrine Abstracts.
Publication Year :
2014
Publisher :
Bioscientifica, 2014.

Subjects

Subjects :
medicine.medical_specialty
business.industry
Octreotide
Pharmacology
Octreotide lar
Repeat dose
Bioavailability
Endocrinology
Internal medicine
Healthy volunteers
medicine
Open label
business
medicine.drug

Details

ISSN :
14796848
Database :
OpenAIRE
Journal :
Endocrine Abstracts
Accession number :
edsair.doi...........8f37472c4d089384012d329a5fd0cb59
Full Text :
https://doi.org/10.1530/endoabs.35.p914
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details